Internal Medicine Alert – May 30, 2006
May 30, 2006
View Issues
-
When to Resume Full Activities Including Work After an Acute Myocardial Infarction
A return to full normal activities, including work at 2 weeks, after AMI appears to be safe in patients who are stratified to a low-risk group. -
Many Factors are Responsible for Treatment Outcome in Acute Exacerbations of Chronic Bronchitis
The number of previous acute exacerbations of chronic bronchitis (AECBs) and the baseline FEV1 level are potent prognostic factors of the short- and long-term outcomes of AECB. -
A Placebo-Controlled Trial of Itopride in Dyspepsia
Itopride, a D2 dopamine agonist with anticholinesterase effects, was marginally superior to placebo in 'functional dyspepsia.' -
What are the Earliest Symptoms of Dementia with Lewy Bodies?
Visual hallucinations, extrapyramidal motor signs, and visuoconstructional impairments at time of presentation are strongly suggestive of a diagnosis of dementia with Lewy bodies. -
Abatacept Infusion (Orencia®)
A novel T-cell inhibitor has been approved for the treatment of rheumatoid arthritis. Abatacept is the first selective modulator of a costimulatory signal involved in T-cell activation (costimulatory blocker). -
Clinical Briefs By Louis Kuritzky, MD
Although aspirin (ASA), particularly low-dose ASA 81 mg/d (LD-ASA), is well established as an appropriate agent for secondary prevention of cardiovascular disease, recent results from the Women's Health Study (WHS) about the impact of ASA in primary prevention came as a surprise...